Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
17.37
-0.33 (-1.86%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Kura Oncology Employees
Kura Oncology had 142 employees as of December 31, 2023. The number of employees increased by 9 or 6.77% compared to the previous year.
Employees
142
Change (1Y)
9
Growth (1Y)
6.77%
Revenue / Employee
n/a
Profits / Employee
-$1,279,930
Market Cap
1.33B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AtriCure | 1,200 |
Dynavax Technologies | 408 |
Travere Therapeutics | 380 |
Ardelyx | 267 |
Tarsus Pharmaceuticals | 244 |
Avadel Pharmaceuticals | 154 |
Enliven Therapeutics | 46 |
Cassava Sciences | 29 |
KURA News
- 22 days ago - Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology - GlobeNewsWire
- 5 weeks ago - Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors - GlobeNewsWire
- 2 months ago - Kura Oncology, Inc. (KURA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST) - GlobeNewsWire
- 2 months ago - Kura Oncology to Report Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes - GlobeNewsWire
- 4 months ago - Life Science Cares San Diego Teams with Kura Oncology to Support Nutritional Needs of the San Diego Community - Business Wire